Achieving Scannable GS1 Codes for DSCSA Compliance

Counterfeit and diverted pharmaceuticals are major problems that put consumer health and company reputations at risk in the global market. As part of an effort to overhaul track and trace rules and increase the accuracy of supply chain information, the U.S. Food and Drug Administration (FDA) is implementing widespread changes for the pharmaceutical industry.

Please note: That all fields marked with an asterisk (*) are required.